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human colorectal mucosa. Inflammation, hypoxia, and 5-aminosalicylic acid increase
H2O2 production supporting innate defense and mucosal healing. Thiocyanate reacts
with H2O2 in the presence of lactoperoxidase (LPO) to form hypothiocyanate (OSCN-),
which acts as a biocide and H2O2 scavenging system to reduce damage during
inflammation. We aimed to discover the organization of Duox2, Duoxa2 and Lpo
expression in colonic crypts of mice, and how distributions respond to Dextran Sodium
Sulphate (DSS)-induced colitis and subsequent mucosal regeneration.
Methods: we studied tissue from DSS exposed mice and human biopsies using in situ
hybridisation, Reverse Transcription-quantitative PCR and cDNA microarray analysis.
Results: Duox2 mRNA expression was mostly in the upper crypt quintile whilst Duoxa2
was more apically-focused. Most Lpo mRNA was in the basal quintile, where stem cells
reside. Duox2 and Duoxa2 mRNA were increased during the induction and resolution
of DSS colitis, whilst Lpo expression did not increase during the acute phase. Patterns
of Lpo expression differed from Duox2 in normal, inflamed and regenerative mouse
crypts (p < 0.001). We found no evidence of LPO expression in human gut.
Conclusions: The spatial and temporal separation of H2O2-consuming and -producing
enzymes enables a thiocyanate- H2O2 'scavenging' system in murine intestinal crypts
to protect the stem/proliferative zones from DNA damage, while still supporting higher
H2O2 concentrations apically to aid mucosal healing. The absence of LPO expression
in human gut suggests an alternative mechanism or less protection from DNA damage
during H2O2 driven mucosal healing.
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Background: DUOX2 and DUOXA2 form the predominant H2O2-producing system in 
human colorectal mucosa. Inflammation, hypoxia, and 5-aminosalicylic acid increase 
H2O2 production supporting innate defense and mucosal healing. Thiocyanate reacts 
with H2O2 in the presence of lactoperoxidase (LPO) to form hypothiocyanate (OSCN-), 
which acts as a biocide and H2O2 scavenging system to reduce damage during 
inflammation. We aimed to discover the organization of Duox2, Duoxa2 and Lpo 
expression in colonic crypts of mice, and how distributions respond to Dextran Sodium 
Sulphate (DSS)-induced colitis and subsequent mucosal regeneration. 
Methods: we studied tissue from DSS exposed mice and human biopsies using in situ 
hybridisation, Reverse Transcription-quantitative PCR and cDNA microarray analysis. 
Results: Duox2 mRNA expression was mostly in the upper crypt quintile whilst Duoxa2 
was more apically-focused. Most Lpo mRNA was in the basal quintile, where stem cells 
reside. Duox2 and Duoxa2 mRNA were increased during the induction and resolution 
of DSS colitis, whilst Lpo expression did not increase during the acute phase. Patterns 
of Lpo expression differed from Duox2 in normal, inflamed and regenerative mouse 
crypts (p < 0.001). We found no evidence of LPO expression in human gut. 
Conclusions: The spatial and temporal separation of H2O2-consuming and -producing 
enzymes enables a thiocyanate- H2O2 ‘scavenging’ system in murine intestinal crypts 
to protect the stem/proliferative zones from DNA damage, while still supporting higher 
H2O2 concentrations apically to aid mucosal healing. The absence of LPO expression 
in human gut suggests an alternative mechanism or less protection from DNA damage 




































































Host defence and control of commensal bacterial populations in the gut of a broad 
range of species, including flies, fish and mammals, involves the dual oxidase enzyme 
(DUOX) acting in concert with its obligate maturation factor/partner encoded by an 
adjacent gene (DUOXA).1,2 Recently, we reported that DUOX2/DUOXA2 form the 
predominant H2O2-producing enzyme system in human colorectal mucosa,3 which is 
capable of releasing significant quantities of H2O2 from the epithelial layer into the gut 
lumen as part of the innate immune response. The DUOX2/DUOXA2 system is 
upregulated during bacterial infection and specifically during inflammatory bowel 
disease (IBD); the genes are regulated on a crypt-by-crypt basis in the colitic mucosa.3 
Loss of Duox2 activity in Duoxa−/− mice negates inflammatory response and permits 
gastric colonization by Helicobacter felis, highlighting the essential role of epithelial 
production of H2O2 in restricting microbial colonisation.4  
 
H2O2 has significant toxicity, killing some pathogens at sub-milli-molar concentration, 
and has a relatively long half-life in vivo so that significant concentrations are achieved 
distant from external cell membranes by diffusion. However, pathogens such as 
Campylobacter jejuni,5 Helicobacter pylori,6 Helicobacter hepaticus,7 and 
enterobacteriaceae family bacteria,8 including Escherichia coli, Shigella, and 
Salmonella produce catalase to deactivate H2O2 allowing the pathogen to escape the 
host’s innate immune response. Catalase activity is lower in colorectal cancer (CRC),9 
gastric adenocarcinoma, and H. pylori-infected stomach,10 compared to normal tissues, 
and mononuclear cells of patients with Crohn's disease (CD) show suppressed 
catalase activity.11 Colitis and colonic tumour burden in treated mice is reduced by oral 
administration of genetically modified catalase-proficient Lactobacilli.12,13 Certain 



































































concentrations drives DUOX expression and H2O2 release.14 Consequently, H2O2 is 
well suited to modulating the number and type of gut pathogens, which in turn can 
counter the host’s response by altering the microenvironment to their advantage.  
 
H2O2 can be reduced by a halide to produce a range of compounds with stronger 
biocidal effects. Thiocyanate (principally from dietary sources) reacts with H2O2 in the 
presence of the enzyme lactoperoxidase (LPO) to form the powerful broad-spectrum 
biocide hypothiocyanate (OSCN–) that is effective against a wide range of bacteria, 
viruses, yeast and fungi.15 These reactions also serve to consume H2O2, reducing the 
potential to damage host DNA through induction of single- and double-strand breaks.16 
In the respiratory tract DUOX1/DUOX1A are the principal producers of H2O2. Both are 
expressed, together with LPO, by subsets of cells within submucosal glands of airways, 
and protect the respiratory tract of mammals from pathogens. In cystic fibrosis the 
H2O2/thiocyanate/LPO system may be compromised due to mutation of the CFTR 
gene. The consequent reduced consumption of H2O2 then damages lung 
parenchyma.17 It remains to be demonstrated that the H2O2/thiocyanate/LPO system is 
active in both human and mouse bowel. 
 
Our recent study was the first to detail the site of expression of DUOX2 and DUOXA2 
in human colorectal epithelium and show their relationship to inflammation and DNA 
damage.3 Animal models of colitis might now offer a way to understand more clearly 
the regulatory pathways involved, their dynamics, and to test novel interventions. Colitis 
can be induced in mice in a number of ways, including exposure to dextran sodium 
sulphate (DSS) in the drinking water. The severity of the induced-colitis varies between 
mouse strains and the genetic basis is not well defined. Esworthy and colleagues used 



































































the Glutathione Peroxidase (GPX) 1 and GPX2 scavenging enzymes and quantitative 
trait loci mapping to identify genes that influence the severity of colitis.18 They identified 
Duox2 and Duoxa2 organised on mouse Chromosome 2 in a head to head orientation 
as one of the top-ranked loci.19 Susceptible and non-susceptible background mouse 
strains both expressed Lpo within epithelial cells of the gut mucosa, but with different 
immuno-staining intensity.20 Thus the H2O2/thiocyanate/Lpo system is available in the 
mouse gut as well as lung.  However, it remained to be seen if Duox2/DuoxA2 and Lpo 
are co-expressed in the normal intestine and/or during a DSS-induced inflammatory 
flare. 
 
In this study, we sought to discover how Duox2, Duoxa2 and Lpo expression is 
organised in colonic crypts of normal mice, and how these distributions respond to DSS 
colitis. The DSS colitis model is the most extensively use model of its type and has 
been reported on many times in the literature. For any given strain of mouse and at a 
particular dosage the model is highly reproducibility. We choose to focus our analysis 
of expression on substantial numbers of crypts within the colon. As there are no 
antisera available to demonstrate specifically Duox2 and Duoxa2 in formalin-fixed 
paraffin-embedded (FFPE) mouse tissues, we assessed mRNA distributions using 
highly specific and sensitive RNAscope® in situ hybridisation (ISH) to generate discrete 
signal dots from mRNA targets.  This allowed us to observe precisely where Duox2, 
Duoxa2 and Lpo were expressed normally and assess how they were modulated in 



































































MATERIALS AND METHODS 
 
Dextran Sulphate-Sodium salt colitis model 
C57BL/6 wild-type mice were maintained under pathogen-free conditions and housed 
in filter-top cages at the animal facility of Fondazione IRCCS Istituto Nazionale dei 
Tumori, Milano. Animal experiments were approved by the Institutional Ethics 
Committee for Animal Experimentation and by the Italian Ministry of Health 
(Authorization Number INT07/2009).  
 
DSS (ThermoFisher Scientific, Italy) was administered for 10 days in drinking water at 
1.5% w/v.  Monitoring loss of body weight from day 0 was used to follow disease 
course. After DSS withdrawal, mice were followed for transition from acute 
inflammation to the recovery phase.  
 
Histology 
Colons were dissected without exposure to DSS or after 3, 10, 14 and 17 days, washed 
in phosphate-buffered saline (PBS), fixed and embedding in paraffin wax. The extent of 
colon inflammation was determined by analysing grade and extension of colitis and 
glandular dysplasia.21,22 
 
Human tissues  
Use of human material received ethical approval (P/01/023) and all participants 
provided written informed consent. Samples from human sporadic rectal cancer, active 
and inactive CD and tumour from ulcerative colitis (UC) patient were used for both 
immunohistochemistry (IHC) and ISH studies. Intramucosal glands within airways were 




































































In Situ Hybridisation 
Probe sets for specific detection of mouse Duox2, Duoxa2 and Lpo and human DUOX2 
and LPO mRNAs, together with appropriate positive control (peptidylprolyl isomerase 
B, PPIB and Ppib) and negative control (dihydrodipicolinate reductase, Dapb) probe 
sets and RNAscope® 2.0 (brown) kits were purchased from Advanced Cell Diagnostics 
(ACD) (Newark, CA, USA). These were used on 4 µm sections following 
manufacturer’s instructions (protease treatment at 1:15, incubations at 40 °C in HybEz 
oven).  Dual ISH for Duox2 and Duoxa2 yielding green/blue and red signals 
respectively was carried out as a contract service by ACD: serial sections were 
hybridised with either Duox2 probe, Duoxa2 probe, both probes, or no probe to allow 
colocalisation and any non-specific signals to be assessed in mouse tissues from d0, 
d3 and d10 of DSS protocol. Slides were scanned using a 20x objective (NanoZoomer 
2.0 H-T, Hamamatsu Photonics UK Limited, Welwyn Garden City, UK) and saved as 
.ndpi files. For mouse sections NDPview2 for Macintosh (Hamamatsu Photonics UK 
Limited) was used to make .ndpa annotations marking areas showing well-orientated 
crypts of normal appearance, close to mucosa inflammation, or of regenerative 
phenotype (poorly differentiated epithelium, mitoses other than close to crypt bases, 
goblet cell depletion) that were viewed with a x60 virtual objective then exported as .tiff 
files (Fig., Supplemental Digital Content 1 for examples). Adobe Photoshop CS5 
(www.adobe.com/uk/) and a Wacom Bamboo graphics tablet (www.wacom.eu) were 
used to mark manually (with a 9 pixel tool) the position of each of up to several hundred 
mRNA signal dots per crypt in multiple individual crypts for each probe at each 
timepoint. A scalar element marked quintiles and the polygonal lasso tool estimated by 
area the number of signal pixels in each fifth of each crypt assessed.  Crypt height was 





































































Reverse Transcription- quantitative PCR (RT-qPCR) analysis   
Colons were rinsed with PBS, homogenized in Trizol reagent and total RNA extracted 
using RNAeasy Mini Kits (Qiagen, Tokyo, Japan), quantified and checked for purity by 
spectrophotometry (Nanodrop, Thermo Scientific). RNA (100ng) was reverse 
transcribed using a High Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems). The qPCR steps used Duox2, Lpo and Rplpo (large ribosomal protein 
RNA; internal control) probe sets (Life Technologies) with n=40 amplification cycles 
according to the manufacturer’s protocol. Melt curve analysis supported that only single 
products accumulated. Relative fold-change normalised to Rplpo was calculated for 
each mouse.  
 
Statistical analyses 
Statistical analysis was performed in R statistical programming language using the 
(non)linear mixed effects model package (nlme). Nested linear mixed effects models 
tested various hypotheses (see Results section) adjusting for possible confounding 
factors such as mouse-specific or crypt-specific effects. Nested models imposed 
increasing levels of model complexity (interactions) and the most significant models 
were chosen by comparing the likelihoods associated with the different models using 
the anova() function. 
 
cDNA microarray analysis 
To investigate LPO expression levels in human large intestine we interrogated the GEO 
database and extracted three studies that have generated gene expression profiles of 



































































human tissues using an ABI human genome array.23 Study B generated gene 
expression profiles of 42 normal human tissues on custom high-density microarrays.24 
Study C performed genome-wide expression profiling of 36 types of normal human 
tissues using an Affymetrix Human Genome Array.25 We extracted the GEO profile 
graphs of the probes that correspond to LPO gene and summarised the expression 
values for normal tissue of interest (colon) and tissues for which expression of LPO is 
highest (salivary gland and trachea). 
 
To further investigate LPO expression levels in human large intestine during 
inflammation and in comparison to DUOX2 we extracted three additional studies on 
UC. Study A performed whole-genome transcriptional analysis of colonic biopsies from 
patients with histologically active (n=15) and inactive UC (n=7), and non-IBD controls 
(n=13) using an Affymetrix microarray.26 Study B analysed inflamed (n=63) and un-
inflamed (n=66) colon epithelial biopsies of 67 UC patients from different anatomical 
locations of the gastrointestinal tract using an Agilent microarray platform.27 Finally, 
study C analysed colonic mucosa samples from UC patients with (n=8) or without 
(n=13) signs of inflammation using an Affymetrix microarray.28 We again extracted 
GEO profile graphs of probes that correspond to LPO and DUOX2 genes and 
summarised expression values across replicates. To test for statistically significant 
differences between conditions, two-sided Student’s t-test was used. It should be noted 
that since each study has used a different microarray platform and normalisation 
method, the expression levels presented are not always on the same scale and hence 
we cannot directly perform a between-studies comparison. 
 
RESULTS 



































































Analysis of homogenates although quantitative, or relative to an internal control such as 
a ribosomal protein RNA, cannot reveal which cells are expressing the mRNAs or 
where changes occur during the acute and recovery phases of DSS colitis. We 
assessed this by ISH using RNAscope 2.0 branched DNA detection.  We chose this 
ISH technology because of its intrinsic high specificity and sensitivity that results in a 
brown dot of reaction product potentially from each single mRNA (see Fig., 
Supplemental Digital Content 1). We confined our transcript counting to crypts in 
regions that presented good longitudinal sections that gave results for all probes, and 
this precluded scoring tortuous crypts or assessing incomplete regenerative 
monolayers. The distributions of Duox2 and Lpo mRNAs in normal crypts prior to DSS 
exposure were clearly different: both were expressed exclusively in epithelial cells, but 
Duox2 was expressed mostly in the upper quintile close to the gut lumen and potential 
pathogens, whereas most Lpo was found in the basal quintile, where proliferative and 
stem cells reside (Fig. 1).  
 
Distribution of Duox2 mRNA expression alters during the acute colitic phases 
and regeneration 
To assess whether and how Duox2 and Lpo expression were modulated in a condition 
of inflammation, C57BL/6 animals were treated with DSS to induce colitis. Mice 
developed symptoms and showed intestinal pathology as expected from the dose of 
DSS and the susceptibility of the C57BL/6 strain used (Fig. 2A, B). In the initial acute 
phase (d3), Duox2 remained abundant at the tops of crypts but also became expressed 
strongly in crypt bases; this disturbance resolved in crypts of normal appearance over 
the next week. Crypts near inflammation showed disturbed patterns of expression in 
the acute phase that became more normal in the recovery phase.  Crypts adjacent to 



































































these elongated glands initially showed no gradient of Duox2 expression (Fig. 3A), but 
these matured somewhat to reflect the patterns seen in inflamed crypts (Fig. 3B). 
 
We assessed our observation statistically using three nested linear models with (i) no 
day effect, (ii) fixed day effect and a (iii) quintile-day interaction effect. The quintile-day 
interaction model was found to be the best model suggesting that the distribution of 
Duox2 mRNA does indeed change during the time course. Examining regression 
coefficients, the coefficients associated with quintile C on d3 (p = 0.0002) and quintile B 
and C on d10 (p = 0.0026 and p = 0.0022) were significant and showed a reduction in 
Duox2. Next, we tested whether distribution of Duox2 within normal and inflamed crypts 
alters on each of the five days using linear models with and without normal-
inflammation interaction terms. The model including the normal-inflammation 
interaction term was statistically significant on days 0, 10 and 14 (p < 0.001, p < 0.001 
and p=0.0015, respectively) indicating differences in distributions in inflamed crypts 
compared to normal crypts. We then asked whether the distribution of Duox2 in 
regenerative crypts was similar to the normal or inflamed pattern, and does this change 
through the time course? This involved comparing the distribution between normal, 
inflamed and regenerative crypts on all days for which data was available. In all 
instances, there was a statistically significant difference between the regenerative 
crypts and normal/inflamed crypts on the same day (p < 0.0001). The distribution of 
Duox2 also changed in regenerative crypts over time (day 14-17; Fig. 3A). 
 
Distribution of Lpo and Duox2 is different in normal, inflamed and regenerative 
crypts 
Distribution and time-course changes were then examined for Lpo expression (Fig. 3C, 



































































effect and a (iii) quintile-day interaction effect. The quintile-day interaction model was 
found to be the best model suggesting that the distribution of Lpo mRNA does indeed 
change during the time course, with the most basal quintile E (containing the stem cell 
compartment) on d10 and the second most-basal quintile D (containing transit 
amplifying cells) on d14 showing distinct differences. When the differences in the 
distribution of Lpo between normal and inflamed crypts on each of the five days were 
examined, all days showed (p < 0.001) statistically significant differences in Lpo 
distributions in inflamed crypts compared to normal crypts.  
 
Lpo was detected in regenerative monolayer epithelium and deep in branching 
regenerative epithelial structures (Fig., Supplemental Digital Content 2), whereas 
Duox2 was expressed most strongly in surface compartments. Maintaining expression 
of Lpo in crypt bases for production of hypothiocyanate would be predicted to help 
consume H2O2 that had diffused to these important regions. Crypts adjacent to 
ulceration and of regenerative phenotype were recognised at d10, d14 and d17, and 
these elongated glands initially showed no gradient of Duox2 expression yet had 
basally-polarized Lpo expression, (Fig. 3C). Over the time course these patterns 
matured somewhat towards those of inflamed crypts. When regenerative and normal 
crypts were compared, we found only significantly differences in distribution of Lpo on 
d10 and d14. In comparison with inflamed crypts, significant differences in distribution 
of Lpo were only found on d10 and d17 (p = 0.0223 and p = 0.0294, respectively). The 
pattern of expression of Lpo differed from that of Duox2 in normal or inflamed or 
regenerative crypts in all instances (p < 0.001). 
 
Next, we used the RT-qPCR assessment of mRNA expression in homogenates to 



































































transcripts. Duox2, but not Lpo levels were increased during the acute phase of 
response to DSS. Duox2 increased at d3 and d11 during the acute phase, and was still 
increased at d14, falling to normal levels or below at d17; Duoxa2 followed the same 
approximate pattern (see Fig. A, B, Supplemental Digital Content 3). In contrast, 
expression of Lpo followed a different pattern dipping slightly at d3 then increasing to a 
maximum at d14 (see Supplemental Digital Content 3, C). As Duox2, Duoxa2 and Lpo 
expression were confined to epithelial cell types there would be no benefit in separating 
the epithelium from stromal cell types (or cells derived from haematopoietic lineages) 
for RT-qPCR experiments. Importantly, the ISH allowed us to look at the distributions 
and ratios of mRNAs along the crypt axis. 
 
Expression of Duox2 and Duoxa2 is regulated independently 
As the gene encoding Duox2 and the gene encoding its obligate accessory protein 
Duoxa2 are adjacent in a head-to-head arrangement, we asked whether Duox2 
expression was co-ordinated with that of Duoxa2 in the acute phase of DSS colitis.  We 
quantified these separately in near serial sections, and also examined sections with 
both mRNAs detected together in different colours. Duoxa2 mRNA had a more extreme 
apically-focussed pattern of expression than did Duox2 (Fig. 4A, B). This supports the 
contention that H2O2 production would normally be confined to the luminal surface, 
closest to gut pathogens and remote from the stem cell compartment where DNA 
damage might have long-lasting consequences. After initiation of DSS colitis, at d3 and 
d10 normal crypts and crypts near inflammation showed much more extensive zones in 
which both Duoxa2 and Duox2 were abundant, and potentially H2O2 production would 
be enhanced (Fig. 4C).  
 



































































Using ISH we and others have been able to detect DUOX2 mRNA expression in 
intestinal epithelium of patients with UC (reported previously in 3) and in Figure 5 we 
show detection of DUOX2 in normal surface epithelium and a cancer from a UC patient 
(Fig. 5A-D) whilst LPO was not detected in serial sections (Fig. 5E-H). In addition, 
using ISH we found DUOX2, but not LPO mRNA, detectable in the small intestine of a 
Crohn’s Disease patient.  We established that the LPO ISH probeset worked (positive 
control) by detecting LPO expression in human upper airway glandular epithelium (see 
Supplemental Digital Content 4).  
 
We sought further confirmation of our ISH findings by interrogating the gene signatures 
from cDNA microarray analysis of multiple normal tissues performed by three 
independent studies (Study A-C).23-25 Our analysis found that LPO is not expressed in 
most human tissues including colon (see Supplemental Digital Content 5), but shows 
high levels of expression in salivary gland and trachea (Fig. 6A). To confirm the 
absence of expression of human LPO during inflammation, we interrogated the 
expression profiles of LPO in UC as measured by three independent studies, Study A-
C.26-28 We found that although DUOX2 expression in colon increases during 
inflammation (two-sided t-test p-value between UC inflamed and controls: 3.933 x 10-08, 
1.435 x 10-13 and 0.0001147 for each of three studies respectively), LPO remains 
unchanged (two-sided t-test p-value between UC inflamed and controls: 0.1043, 
0.06567 and 0.6089 for each of three studies respectively) (Figure 6B and see 
Supplemental Digital Content 6).  
 
DISCUSSION 
Previous studies attempted to localize DUOX2 in non-DSS exposed human and rodent 



































































example, El Hassani and colleagues showed evidence for localization of human 
DUOX2 by using a rabbit polyclonal antiserum, but that also stained the muscularis 
mucosae non-specifically.29 Apical immunofluorescence for Duox was shown in mouse 
cells grown as organoids, but this relied on a pan-duox antibody.30 ISH using a 35S 
riboprobe was interpreted to show that duox2 mRNA was present predominantly in the 
lower half of rat rectal crypts,31 but this gross distribution conflicts with more recent data 
from analysis of mRNA from laser capture microdissection of mouse mucosa in which 
apical colonic ‘tip’ pooled RNA had higher levels of Duox2 mRNA than ‘crypt base + 
lamina propria’.32 No previous study has localised Duox2, Duoxa2 and Lpo or studied 
the effects of DSS.  
 
We found in the mouse that Duox2 and Duoxa2 are expressed in crypts of the large 
bowel normally in a gradient with the strongest expression at the luminal aspect of 
crypts. In crypts close to inflammation the distribution of these mRNAs is perturbed – 
spreading more broadly throughout the crypt. In human UC we reported accentuation 
of DUOX2 and DUOXA2 expression in crypt abscesses that are a feature of human 
UC, but unusual in the mouse (Supplemental Digital Content 2).3 In mouse, we found 
that the normal patterns of Duox2/Duoxa2 and Lpo expression were disrupted following 
DSS exposure; the wider availability of these proteins along the crypt would permit 
generation of greater H2O2 concentrations nearer the crypt base and with the potential 
for genetic damage in stem cells. Such damage might explain partly the increased risk 
of CRC in IBD patients.33 
 
The DSS colitis protocol limits sampling to discrete time points: here, we made 
observations by ISH and counted transcripts at Day 0 (no DSS treatment) and at Day 3 



































































In the absence of continuous monitoring, only a limited number of snapshots of the 
progressive changes in expression can be provided. Nevertheless, we can provide the 
first assessment of Duox2/Duoxa2 changes in the mouse DSS-induced colitic colon. 
We have found that the two obligate genes for direct production of H2O2 are affected in 
broadly similar ways during the induction and resolution of DSS colitis in mice. 
However, Duoxa2 appears more tightly confined and may be subject to subtly different 
regulation potentially to limit any genetic damage to stem cells at the base of crypts. 
Studies of isolated crypts would offer a way to resolve more precisely the rapidity of 
each genes’ response to DSS, other damaging agents or bacteria and the potential to 
assess the site of production and yield of H2O2 using very specific probes recently 
developed.30 34 To our knowledge there are at present no specific inhibitors of 
Duox2/Duoxa2 or Lpo with which to study the action of this system ex vivo, so it may 
be necessary to pursue knockdown strategies to determine the protective effects of Lpo 
against DNA damage in isolated murine crypts.  However, if LPO is absent from human 
crypts, mouse models of colitis for understanding the risk of cancer in colitis will not 
take into account this difference between species. 
 
LPO is important for generating biocidal compounds for bacterial defence following 
breaches in epithelial integrity and for consuming the additional H2O2 produced in 
response to damage that might otherwise damage host cell DNA. Lpo expression in the 
mouse gut has been assessed immunohistochemically and at the mRNA level, and 
varies between mouse strains.20 By immunohistochemistry, Lpo appears apical 20, yet 
data within supplementary tables of Sommer et al  support Lpo being basal in dissected 
normal crypts (± germ free),35 and our present results show it is normally basal, but 
more widespread in regenerative gland epithelium.  In distinct contrast to the mouse, 



































































bowel. In contrast, LPO protein and mRNA are expressed in human intramucosal 
glands of high order airways.  The human LPO probe we used gave clear signals in 
positive control airway tissue, but not in the large bowel. Similarly, IHC could detect no 
protein expression and we did not find evidence for LPO expression in human large 
bowel samples during analysis of available microarray data sets for UC and normal 
bowel tissues. These findings support our experimental evidence that LPO is largely 
absent in human large bowel. We perceive this deficit to be a major unexplained 
difference in host defence between man and mouse.  
 
In conclusion, H2O2 is needed to help in the recruitment of immune cells, mucosal 
healing and the resolution of inflammation. The presence of LPO together with H2O2 
could assist defence via the production of OSCN-. We propose that in mice there is a 
spatial separation of the products of the Lpo and the Duox2/Duoxa2 genes.  Normally 
the Duox2/Duoxa2 genes place the greatest production of H2O2 towards the lumen of 
the intestine and basal expression of Lpo confines H2O2 scavenging and the production 
of the biocidal OSCN- to the crypt base as a second line defense against certain 
pathogens reaching the crypt base. This arrangement would serve to reduce the 
likelihood of enduring DNA damage. Moreover, the increased levels of Lpo during the 
recovery phase from colitis in mice might support both scavenging and OSCN- 
production in vulnerable epithelium.  Mice and men may have evolved different 
mechanisms to cope with their common gut pathogens, although both mechanisms 
serve to maintain H2O2 as a means of enhancing mucosal healing by limiting the extent 
of scavenging. However, the lack of an LPO scavenging action in human gut might 
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Figure 1. Crypt height and the distribution of Duox2 and Lpo within crypts of 
normal appearance before and after exposure to dextran sodium sulphate.  (A) 
Duox2 and (B) Lpo expression in normal crypts at the different time point. Pale blue 
cross shows mean and standard error of mean of crypt height. n= indicates the 
numbers of crypts assessed for signals with the indicated probe.  
 
Figure 2. Experimental protocol, body weight and intestinal changes in response 
to dextran sodium sulphate. (A) Experimental protocol. Time points are given as 
days. Numbers of mice studied overall and number studied using ISH are shown. 



































































bar is 1 mm. The area indicated by an arrow is shown below (scale bar is 250 µm) At 0 
days crypts were of normal morphology. At day 3 (acute phase) just one focus in this 
colon at this level showed mucosal injury induced by DSS. At day 10 (end of DSS 
exposure), damage was more extensive; this region shows inflammatory cells within 
the mucosa and submucosa, several crypts with limited goblet cell morphology and 
abscess-like dilatation; the surface epithelium appears intact. At day 14 (recovery 
phase), extensive ulceration and areas with regenerative glandular structures are 
evident; this region has an almost continuous epithelial covering flanked by simple 
regenerative crypts. At day 17, ulcerated mucosa and regenerating patches are still 
present, but large areas of mucosa appear macroscopically normal; this region shows 
branching/budding crypt bases surrounded by inflamed stroma, similar to the structures 
expressing Lpo basally in Supplemental Digital Content 2.  
 
Figure 3. Duox2 and Lpo expression in crypts near inflammation and in 
regenerative crypts after dextran sodium sulphate exposure in mice. (A) Duox2 
expression in crypts at the different time point.  (B) Representative images of Duox2 in 
situ hybridisation at day 10 and 14. (C) Lpo expression in crypts at the different time 
point. (D) Representative images of Lpo in situ hybridisation at day 10 and 14. n= 
indicates the numbers of crypts assessed for signals with the indicated probe. Pale 
blue cross shows mean and standard error of mean of crypt height. See Supplemental 
Digital Content 2 for additional examples. 
 
Figure 4. Effects of dextran sodium sulphate on the distribution of Duoxa2, Duox2 
and the ratio Duoxa2:Duox2 within crypts. Crypt height is given by reference to 
scale bar. The Duoxa2:Duox2 ratio used average values for each quintile. Pale blue 




































































Figure 5. The presence of DUOX2 and absence of LPO in intestinal epithelium and 
cancer from a patient with ulcerative colitis (UC). (A) ISH for DUOX2 in normal 
epithelium from an UC patient shown at low power; (B) ISH for LPO in normal 
epithelium of the same UC patient at low power; (C) DUOX2 in normal epithelium from 
UC patient shown at high power. (D) LPO in normal epithelium from UC patient at high 
power. (E) DUOX2 in cancer from UC patient at low power. (F) LPO in cancer from UC 
patient at low power. (G) DUOX2 in cancer from UC patient at high power. (H) LPO in 
cancer from UC patient at high power. Arrows denote positive cells. Low power scale 
bars = 250 µm, high power scale bars = 50 µm. See also Supplemental Digital Content 
4. 
 
Figure 6. LPO is expressed at high levels in salivary gland and trachea and is 
unresponsive to inflammation in the ulcerative colitis colon. (A) LPO expression in 
salivary gland, trachea and colon as measured by three microarray studies (Study A-
C).23-25 (B) LPO and DUOX2 expression in UC inflamed colon, UC uninflamed colon 
and controls as measured by three additional microarray studies (Study A: colonic 
biopsies from patients with histologically active (n=15) and inactive UC (n=7), and non-
IBD controls (n=13);26 Study B: inflamed (n=63) and un-inflamed (n=66) colon epithelial 
biopsies of 67 UC patients;27 and Study C: colonic mucosa samples from UC patients 



































































SUPPLEMENTAL DIGITAL CONTENTS 
 
Supplemental figure legends 
 
Supplemental digital content 1. Examples of Duox2, Duoxa2 and Lpo mRNA ISH 
signal dots and their counting in quintiles. (A) An example of an image exported 
from a NanoZoomer scan, with Duox2 mRNA signal brown dots (in a region of D17 
mouse colon with crypts of normal appearance) marked in magenta with a 9 pixel brush 
and with quintile scale in place.  Total signal area (pixels) was measured for each fifth 
of an individual crypt’s height.  Crypt height was scaled from the size bar generated in 
NDPview2 software. (B) An example of Duoxa2 mRNA signals (marked when scored) 
in normal crypts of a D0 mouse colon; not that signals are tightly grouped in the most 
apical fifth of the crypt. (C) A pair of near-serial sections showing Duox2 (left) and Lpo 
(right) mRNA ISH signals in a large crowded crypt with limited goblet cell phenotypes 
and considered regenerative in the colon of a D14 mouse.  Note that nearby 
inflammatory cells show no ISH signals. 
 
 
Supplemental digital content 2. Examples of ISH results showing Duox2, Duoxa2 or 
Lpo expression patterns in features of DSS colitis. D10, both Duox2 (blue/green 
signal dots) and Duoxa2 mRNAs (red signal dots; near–serial section) are abundant 
apically, but also deep within regenerating glands (RG) in this severely inflamed region 
of colon. No expression was detected outside the epithelium. Note that individual ISH 
signal dots are smaller than one pixel in these panels. D14, widespread expression of 
Duoxa2 and Lpo mRNAs deep within crypts; Duox2 is conspicuous in the abscessed 



































































healing ulcer expresses Duox2 and variably Lpo mRNAs; the orientation is not perfectly 
in cross-section, but mRNA signals appear located mainly towards the apical surface of 
the epithelial monolayer. D17, Duox2 and to a much lesser extent Lpo mRNAs are 
present in the epithelial monolayer (m) in this late-stage lesion. The lymphoid 
aggregates (LA) and other stromal components appear unlabelled, yet both mRNAs 
are present throughout the epithelium, with Lpo conspicuously abundant deep in the 
branching/bifurcating glands. Individual signal dots can be seen in the enlarged regions 
indicated by red and green boxes. 
 
Supplemental digital content 3. Duox2, but not Lpo abundance increases during the 
acute phase of response to DSS in the drinking water of mice. Relative levels of 
Duox2 mRNA (panel A), Duoxa2 (B) and Lpo (C) assessed by RT-qPCR. Number of 
mice shown on bars. Statistical differences were evaluated using one-way ANOVA 
corrected for multiple testing and no significant differences were identified between day 
0 and days post-exposure for A-C. 
 
Supplemental digital content 4. LPO is expressed in human upper airway but not in 
the intestine of Crohn’s disease patients with active disease. (A) DUOX2 
expression is present in Crohn’s Disease small bowel with active disease: areas 1 and 
2 shown at greater magnification below. (B) LPO expression is not detectable in a 
section serial to A: areas 1 and 2 shown at greater magnification below. (C) LPO 
expression is detected in human upper airway glandular epithelium used as a positive-
tissue control: areas 1 and 2 shown at greater magnification below. Low power scale 




































































Supplemental digital content 5. LPO is not expressed in the colon or most other 
human tissues. GEO profile graphs of the probes that correspond to the LPO gene as 
quantified by three microarray studies (Study A-C).23-25 
  
Supplemental digital content 6. Data for DUOX2 and LPO in the inflamed colon of 
ulcerative colitis patients. GEO profile graphs of the probes that correspond to LPO 
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